UK doctors trial tiny particle blockage to shrink thyroid lumps
NCT ID NCT07046546
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test the safety of thyroid artery embolization (TAE) in 10 UK patients with benign thyroid nodules or goitre. TAE is a minimally invasive procedure that blocks blood flow to the thyroid gland using tiny particles, causing it to shrink. The goal is to see if it can be safely introduced in the UK, with future larger trials planned to compare it to standard treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Thyroid artery embolization (TAE) - a minimally invasive procedure that blocks thyroid arteries with tiny particles to shrink the gland
What this could lead to
If successful, this could offer a new, less invasive treatment option for people with large thyroid nodules who cannot have surgery or other standard treatments.
What could go wrong
This is a very small pilot study with only 10 patients, focused on safety, not effectiveness. The procedure is new to the UK and may not work as well as hoped or could have unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Royal Berkshire Hospital
RECRUITINGReading, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••